Dr. Kayla Flood

Pediatric Nephrologist, Saskatoon

Project: Reducing the Number of Antibiotic Days for Asymptomatic Bacteriuria

Nephrotic syndrome (NS) increases the risk of invasive pneumococcal disease. It is recommended that all patients with NS receive pneumococcal polysaccharide vaccine (PPSV-23).  This vaccine can be given at the time of diagnosis alongside immunosuppression use. In a retrospective review of all patients with NS followed by pediatric nephrologists in Saskatoon only 37.5% (n=18) had received PPSV-23 and the median time from diagnosis to the first dose was 1.8y (IQR 1, 12.1). We aimed to achieve an 80% vaccination rate among patients with a new diagnosis of NS by their 12-14 week follow up visit and 60% among patients with an existing diagnosis of NS. We implemented both a standardized operating procedure and clinical order set to help standardize care and increase vaccine administration.  Studying the results of this intervention is ongoing and we will use our results to guide further PDSA cycles

QIck Talk Video

Back to all Cohort 5 projects


Dr. Kayla Flood

Reducing the Number of Antibiotic Days for Asymptomatic Bacteriuria

Contact Us